Welcome Dr. Joshua D. Rosenblat
We would like to welcome Dr. Joshua D. Rosenblat (Assistant Professor, Clinician-Investigator, Department of Psychiatry; Psychiatrist and Clinician-Researcher, Mood Disorders Psychopharmacology Unit, Toronto Western Hospital; Medical Director, Canadian Rapid Treatment Centre of Excellence, Braxia Health; Chief Medical & Scientific Officer; Braxia Scientific; Co-Founder, 1907 Research), as a new faculty member to the CPIN community.
Dr. Rosenblat completed his Bachelors of Science at the University of Toronto. He then completed his medical degree at the Schulich School of Medicine at the University of Western Ontario (UWO). He returned to Toronto to complete his residency training in the Department of Psychiatry where he also served as the Chief Resident of the Clinician-Scientist Program (CSP). Throughout medical school and residency, he conducted clinical research on novel pharmacological interventions for mood disorders. He then completed his graduate training in the Department of Pharmacology & Toxicology, studying the effects of ketamine for depression.
Dr. Rosenblat’s clinical focus is on mood disorders, with specialized expertise in pharmacological treatments. He conducts clinical trials to identify and evaluate novel psychopharmacological interventions for mood disorders that may substantially improve patient outcomes. Specific research programs currently underway include clinical trials evaluating ketamine and psilocybin assisted therapy for bipolar and unipolar depression. He has authored and co-authored >150 journal articles and textbook chapters in prestigious journals, such as the New England Journal of Medicine, JAMA Psychiatry, the American Journal of Psychiatry and the Journal of Clinical Psychiatry. He has received numerous local, national and international grants and awards for his research in mood disorders.
